Brief: Cancer Genetics Says Director Resigned From Board
July 19 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS SAYS ON JULY 8, BOARD GOT LETTER FROM JOHN
PAPPAJOHN AS PER WHICH HE RESIGNED AS DIRECTOR OF BOARD,
EFFECTIVE IMMEDIATELY - SEC FILING
* CANCER GENETICS SAYS JOHN PAPPAJOHN, IN JULY 8 LETTER TO
CO,
SAYS HE WILL VOTE AGAINST CO'S ANNOUNCED AGREEMENT WITH
INTERFACE
Source text: [https://bit.ly/2Gk0EEK]
Further company coverage: CGIX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration